Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 6/20 | 0.38 |
| ▸ | DDB1 | Q16531 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28226112 | 0.83 | DDB1 (0.33) | POLBCRBNDDB1CYP19A1 | |
| SCHEMBL8080480 | 0.82 | POLB (0.33) | POLBTSHRALOX15 | |
| SCHEMBL10597719 | 0.82 | MAP3K14 (0.38) | MAP3K14CRBNDDB1TSHRGAA | |
| SCHEMBL2128127 | 0.82 | CRBN (0.35) | MAP3K14POLBCRBNDDB1MEN1 | |
| SCHEMBL4396268 | 0.82 | CRBN (0.35) | MAP3K14CRBNDDB1MEN1APEX1 | |
| SCHEMBL3949247 | 0.82 | MAP3K14 (0.40) | MAP3K14CRBNDDB1TSHRMEN1 | |
| SCHEMBL7264550 | 0.82 | MAP3K14 (0.40) | MAP3K14CRBNDDB1TSHRMEN1 | |
| SCHEMBL756451 | 0.81 | CRBN (0.38) | MAP3K14CRBNDDB1TSHRMEN1 | |
| SCHEMBL8092079 | 0.81 | POLB (0.32) | POLBTSHRALOX15 | |
| SCHEMBL26328452 | 0.81 | DDB1 (0.52) | CRBNDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114438048-B | Urate oxidase preparation and application thereof | 重庆派金生物科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118497161-A | Polyethylene glycol modified urate oxidase | 重庆派金生物科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-117866929-A | Pegylated arginine deiminase dimer preparation and use thereof | 重庆派金生物科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| WO-2023079959-A1 | SILICONE ADDITIVE FOR RESIN MODIFICATION AND CURABLE RESIN COMPOSITION CONTAINING SAME | 信越化学工業株式会社 | 2023-05-11 | — | — | WO | claimed |
| CN-115997016-A | Composition comprising nucleic acid nanoparticles having modular functional groups | 西克斯福德生物科学有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-114438048-A | Urate oxidase preparation and application thereof | 重庆派金生物科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-111909906-A | Urate oxidase modified by polyethylene glycol | 重庆派金生物科技有限公司 | 2020-11-10 | — | — | CN | claimed |
| WO-2006006924-A1 | METHOD AND KIT FOR PEPTIDE ANALYSIS | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2006-01-19 | — | — | WO | claimed |
| EP-1432992-A2 | CONTROLLING ISOTOPE EFFECTS DURING FRACTIONATION OF ANALYTES | PURDUE RESEARCH FOUNDATION (US) | 2004-06-30 | — | — | EP | claimed |
| EP-1370295-A2 | NEUTRAL AND ANIONIC COLLOIDAL PARTICLES FOR GENE DELIVERY | GENCELL S.A. (FR) | 2003-12-17 | — | — | EP | claimed |
| WO-2003027682-A2 | CONTROLLING ISOTOPE EFFECTS DURING FRACTIONATION OF ANALYTES | PURDUE RESEARCH FOUNDATION (US) | 2003-04-03 | — | — | WO | claimed |
| WO-2002043769-A2 | NEUTRAL AND ANIONIC COLLOIDAL PARTICLES FOR GENE DELIVERY | GENCELL S.A. (FR) | 2002-06-06 | — | — | WO | claimed |
| CN-120202229-A | Curable polymer compound and resin composition containing the same | 日本化药株式会社 | 2025-06-24 | — | — | CN | disclosed |
| CN-118852124-A | Preparation method and application of indole alkaloid compound | 广东医科大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-114438048-B | Urate oxidase preparation and application thereof | 重庆派金生物科技有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-115768805-B | Polymer compound and resin composition containing the same | 日本化药株式会社 | 2024-10-01 | — | — | CN | disclosed |
| US-4801579-A | NUTRIENT SOLUTIONS, WATER SOLUBILITY | BLEIBERGER BERGWERKS UNION (AT) | 1989-01-31 | — | — | US | disclosed |
| US-4783442-A | B-cell differentiating peptides | ORTHO PHARMACEUTICAL CORPORATION (US) | 1988-11-08 | — | — | US | disclosed |
| EP-0203621-A1 | C-20-modified macrolide derivatives | ELI LILLY AND COMPANY (US) | 1986-12-03 | — | — | EP | disclosed |
| EP-0104028-A1 | C-20-modified macrolide derivatives | ELI LILLY AND COMPANY (US) | 1984-03-28 | — | — | EP | disclosed |